Adamax Overview
Adamax is a lab-made nootropic peptide. "Nootropic" means a compound studied for focus, learning, or memory. Adamax starts with the Semax backbone, then adds two chemical groups intended to improve stability and brain entry.
It came out of the nootropics community rather than a formal drug-development program. That matters because Adamax has almost no direct science behind it. Most claims are borrowed from Semax research or based on personal reports.
What it is
A synthetic 9-amino-acid Semax analog with an acetyl group and an adamantane group.
Form
Freeze-dried powder (often 10 mg vials) mixed with BAC water, or a ready-made nasal spray.
Routes
Intranasal (nose) or subcutaneous (under-the-skin) injection, used in short cycles.
Status
Not FDA-approved. Research-use only. No published studies on Adamax itself.
Educational use only
This page is an educational research reference, not medical advice or a treatment plan. Adamax has no clinical trials, and its safety profile is not established.
Adamax Dosing Context & Schedule
Adamax has no trial-based dose because no dosing studies exist. The amounts below come from community use and Semax-style dosing discussions. Treat them as reported patterns, not tested or recommended doses.
Adamax Route Context
Compare how the two common research-use routes are discussed.
Common in nootropics communities.
Like Semax, Adamax is often discussed as nose drops or a nasal spray. This route avoids injections, but a spray product has its own concentration and dose per pump.
- Sold either as a pre-made nasal spray or mixed by the user from powder.
- Community amounts are small, often a few hundred micrograms (mcg) per dose.
- Some users split a daily amount into morning and midday doses.
- A pre-made spray should be evaluated by its stated concentration, not by the SubQ vial math below.
The default route for the vial math on this page.
The SubQ route uses reconstituted powder drawn with a small U-100 insulin syringe. The weekly pattern below is written for this setup.
Syringe units depend on concentration. In the example below, 100 units equals 1 mL, and each unit contains about 33 mcg after mixing 10 mg with 3 mL BAC water.
Community SubQ titration pattern
This pattern is not from a trial. It assumes one 10 mg vial mixed with 3 mL BAC water, creating a concentration of about 3.33 mg/mL. At that strength, one insulin unit (0.01 mL) contains about 33 mcg.
Community-derived weekly pattern (not from trials)
Weeks
Weeks 1-2
Daily dose
300 mcg (0.3 mg)
Volume
0.09 mL
Insulin units
9 units
Weeks
Weeks 3-4
Daily dose
500 mcg (0.5 mg)
Volume
0.15 mL
Insulin units
15 units
Weeks
Weeks 5-6
Daily dose
750 mcg (0.75 mg)
Volume
0.23 mL
Insulin units
23 units
Weeks
Weeks 7-8
Daily dose
1000 mcg (1.0 mg)
Volume
0.30 mL
Insulin units
30 units
| Weeks | Daily dose | Volume | Insulin units |
|---|---|---|---|
| Weeks 1-2 | 300 mcg (0.3 mg) | 0.09 mL | 9 units |
| Weeks 3-4 | 500 mcg (0.5 mg) | 0.15 mL | 15 units |
| Weeks 5-6 | 750 mcg (0.75 mg) | 0.23 mL | 23 units |
| Weeks 7-8 | 1000 mcg (1.0 mg) | 0.30 mL | 30 units |
Volumes and units assume a 10 mg vial in 3 mL BAC water (about 3.33 mg/mL). Community-derived and not trial-validated.
No tested dose exists
Because Adamax has not been studied directly, these amounts should not be treated as proven safe or effective. This is research-context dosing information only.
Adamax Supplies & Course Math
Supply planning here follows the SubQ pattern above: one 10 mg vial mixed with 3.0 mL BAC water, creating about 3.33 mg/mL. Confirm vial size, batch documents, and current product details before ordering.
Recommended USA Supply
Use discount code SAVE10 at Orbitrex Peptides checkout. See why we love Orbitrex Peptides.

Adamax Supply

SiPhox Health At-Home Blood Test
Injection Supplies
Disclosure: supply links may earn PDP a commission at no cost to you.
Adamax Vials
One 10 mg vial covers the 8-week pattern above, which uses about 3.9 mg total, leaving room for priming loss and measurement waste.
| Cycle length | Planning note |
|---|---|
4-8 weeks 1 vial | 4 weeks: About 1.6 mg used in weeks 1-4.; 8 weeks: About 3.9 mg used across weeks 1-8. |
12 weeks 2 vials | Extended or repeated cycles. |
4-8 weeks
1 vial
4 weeks: About 1.6 mg used in weeks 1-4.; 8 weeks: About 3.9 mg used across weeks 1-8.
12 weeks
2 vials
Extended or repeated cycles.
Bacteriostatic Water
Use 3.0 mL per 10 mg vial for the strength above.
| Cycle length | Planning note |
|---|---|
8 weeks 1 x 10 mL bottle | One vial uses 3 mL; one bottle is plenty. |
8 weeks
1 x 10 mL bottle
One vial uses 3 mL; one bottle is plenty.
Insulin Syringes (U-100)
Prefer 0.3 mL / 30-unit syringes for these small draws.
| Cycle length | Planning note |
|---|---|
8 weeks 56 syringes | 1 per day; recommend a 100-count box. |
8 weeks
56 syringes
1 per day; recommend a 100-count box.
Nasal-spray products are already mixed, so the BAC-water and syringe math on this page does not apply to them.
Companion Supplies & Routine Support
Adamax Reconstitution Guide
Reconstitution means adding liquid to freeze-dried powder so it can be measured as a solution. Only powder vials need this step. A pre-made nasal spray is already mixed.
The SubQ pattern on this page assumes a 10 mg vial plus 3.0 mL BAC water. That creates about 3.33 mg/mL, so each insulin unit (0.01 mL) contains roughly 33 mcg.
- 01
Wipe both stoppers
Swab the Adamax vial top and the BAC water vial top with alcohol.
- 02
Draw the water
Pull 3.0 mL of BAC water into a syringe.
- 03
Add it slowly
Let the water run down the inside wall of the vial, not straight onto the powder.
- 04
Do not shake
Swirl gently until the powder dissolves. Shaking can damage the peptide.
- 05
Check the liquid
It should look clear. Discard it if it stays cloudy or has floating bits.
- 06
Store it
Keep the mixed vial in the fridge and use it within a few weeks.
- 07
Draw your dose
Use the units from the dosing table above for the strength you mixed.
Change the water, change the units
If the vial size or BAC-water volume changes, the mcg per unit changes too. Recalculate before copying the table.
How Adamax Is Thought to Work
This section is mostly theory carried over from Semax. Adamax has not been tested directly, so its mechanism has not been confirmed.
Adamax is built on the Semax backbone (Met-Glu-His-Phe-Pro-Gly-Pro), which comes from part of the ACTH hormone. It adds an acetyl group at one end and an adamantane group at the other. Those changes are meant to improve stability and brain entry.
Semax has been studied for effects on BDNF, a protein involved in brain-cell growth and signaling. Adamax is marketed around the idea that similar effects may last longer per dose, but that has not been proven for Adamax.
- Backbone: Semax (an ACTH(4-10)-derived peptide).
- Acetyl group: slows enzyme breakdown (the N-Acetyl Semax idea).
- Adamantane group: adds stability and fat solubility for brain entry.
- Proposed target: the BDNF / TrkB pathway, extrapolated from Semax.
- Key limit: no direct Adamax mechanism data exists.
Who Should Avoid Adamax
Because Adamax has no direct safety research, the practical assumption should be more caution, not less.
- Anyone pregnant or breastfeeding (no safety data).
- Anyone under 18.
- People with a known allergy to Adamax or any component.
- People with a medical condition or prescription medicines unless a clinician has reviewed the risk.
- Anyone who cannot verify the product's source and testing.
Unknown safety
A lack of published harm reports is not proof of safety. Adamax has not been studied enough to rule out unknown risks.
Adamax Side Effects
There is no side-effect dataset for Adamax. The notes below are inferred from Semax, nasal-spray use, and general injection-site issues.
Semax is generally described as well tolerated in research contexts. For Adamax, the likely route-related issues are nasal irritation with sprays or redness, soreness, and bruising with injections. Some users also report stimulation-type effects such as headache, irritability, or poor sleep.
- Nasal route: mild nose or throat irritation.
- Injection route: site redness, soreness, or bruising.
- Possible overstimulation: headache, irritability, poor sleep.
- Unknown: long-term effects and any Adamax-specific risks.
Stop for allergic signs
Rash, swelling, or trouble breathing after any peptide needs emergency care. Stop use and seek help right away.
Adamax Timeline & What Users Report
There are no measured timelines for Adamax. User reports describe focus or motivation changes within the first few hours, but those reports are anecdotes, not controlled data.
- Reported onset: within hours of a dose (anecdotal).
- Claimed edge over Semax: longer duration per dose, still unproven.
- Cycles: users often run short blocks, such as a few weeks on.
- No objective testing backs these reports.
Adamax Clinical Evidence
This is the most important section, and it is short for a reason: there is no direct clinical evidence for Adamax. There are no human trials and no published animal or lab studies testing Adamax itself.
The person associated with Adamax's creation has said it was developed without human clinical research or supporting studies. Ceretropic, the company most closely tied to the original Adamax product, shut down in 2018.
Adamax itself: no published studies
No human or animal studies on Adamax have been published. All benefit and mechanism claims are either anecdotal or borrowed from Semax.
Semax parent peptide: real preclinical work
Semax has genuine research. A 2006 Brain Research study reported that intranasal Semax raised BDNF and activated its TrkB receptor in the rat hippocampus. That finding belongs to Semax, not Adamax.
Semax human-use history
Semax has been used clinically in Russia for stroke and cognitive complaints, but that history does not validate a modified analog like Adamax.
Bottom line
Adamax should be read as an experimental idea with an interesting design and no evidence, not as a proven nootropic.
Check the citations
Some seller pages attach Semax studies or unrelated citations to Adamax. If a citation does not test Adamax directly, it is not Adamax evidence.
Adamax Storage & Handling
Adamax Storage
Unopened / long-term
Adamax powder
-4F (-20C) freezer
Adamax (mixed) / spray
N/A
In use
Adamax powder
35.6-46.4F (2-8C) fridge
Adamax (mixed) / spray
35.6-46.4F (2-8C) fridge
Light
Adamax powder
Keep dark, original vial
Adamax (mixed) / spray
Keep dark
Appearance
Adamax powder
White powder
Adamax (mixed) / spray
Clear liquid
| Adamax powder | Adamax (mixed) / spray | |
|---|---|---|
| Unopened / long-term | -4F (-20C) freezer | N/A |
| In use | 35.6-46.4F (2-8C) fridge | 35.6-46.4F (2-8C) fridge |
| Light | Keep dark, original vial | Keep dark |
| Appearance | White powder | Clear liquid |
Discard mixed solution or spray that turns cloudy, changes color, or has particles.
Keep freeze-dried powder cold and protected from light. Once mixed with BAC water, keep it refrigerated and use it within a short window. Even if Adamax is marketed as more stable than Semax, careful cold storage is still the right assumption.
Adamax Troubleshooting
- Cloudy liquid or visible particles: do not use it. Mixed Adamax should look clear.
- Sourcing doubt: Ceretropic closed in 2018, so product quality can vary. Look for third-party COA testing before trusting a vial.
- Nasal irritation: usually from the spray itself; a lower amount or a break often helps.
- Units feel off: recheck the mixing math, because different BAC water volumes change the mcg per unit.
- Route confusion: a pre-made nasal spray is not measured in insulin units; follow the product's own dosing.
Adamax Regulatory Status
As of July 2026, Adamax is not approved by the FDA or any other major regulator for any medical use. It is generally sold as a research chemical, labeled research-use-only and not for human consumption.
It is not a dietary supplement or an approved prescription drug. Buying it for research does not make personal use legal or safe, and rules vary by country.
Research-use only
Confirm the current rules where you live before buying or importing. Research-use-only material is not intended for human use.
Adamax vs Semax & Related Peptides
Adamax sits in the Semax family. The trade-off is straightforward: the more a peptide is modified, the longer it may be claimed to last, but the less direct evidence may exist for that exact molecule.
Adamax vs Semax vs N-Acetyl Semax vs P21
Feature
What it is
Semax
Base heptapeptide
N-Acetyl Semax
Acetylated Semax
Adamax
Acetyl + adamantane Semax
P21
Separate neurogenic peptide
Feature
Claimed duration
Semax
Shortest
N-Acetyl Semax
Longer
Adamax
Longest (claimed)
P21
N/A
Feature
Evidence
Semax
Preclinical + some clinical
N-Acetyl Semax
Limited
Adamax
None on the compound
P21
Animal studies
Feature
Relation
Semax
Parent
N-Acetyl Semax
Modified parent
Adamax
Borrows P21's adamantane group
P21
Source of that group
| Feature | Semax | N-Acetyl Semax | Adamax | P21 |
|---|---|---|---|---|
| What it is | Base heptapeptide | Acetylated Semax | Acetyl + adamantane Semax | Separate neurogenic peptide |
| Claimed duration | Shortest | Longer | Longest (claimed) | N/A |
| Evidence | Preclinical + some clinical | Limited | None on the compound | Animal studies |
| Relation | Parent | Modified parent | Borrows P21's adamantane group | Source of that group |
These are different molecules with different evidence. They are not interchangeable, and more modification does not mean more proof.
For the better-studied Semax-family option, start with Semax itself. Adamax is the more experimental branch, not the evidence-backed baseline.
FAQ
Q1: What is Adamax?
Adamax is a synthetic nootropic research peptide based on Semax. It adds an acetyl group and an adamantane group, which are meant to make the molecule more stable and longer-lasting.
Q2: What is Adamax used for?
In research and nootropics communities, Adamax is discussed for focus, learning, and memory, similar to Semax. Those uses are not proven, and Adamax is not approved to treat any condition.
Q3: Is there any research on Adamax?
No published human or animal studies test Adamax itself. Most science cited around Adamax is actually Semax research, which cannot be assumed to transfer to a modified analog.
Q4: Is Adamax FDA approved?
No. As of July 2026 it is not approved by the FDA or any major regulator. It is sold as a research chemical labeled research-use-only and not for human consumption.
Q5: Adamax vs Semax: what is the difference?
Adamax is Semax with two extra chemical groups added for claimed stability and brain entry. Semax has direct research behind it; Adamax does not. See the Semax protocol for the better-studied option.
Q6: How is Adamax dosed?
There is no tested Adamax dose. Community SubQ patterns often start at a few hundred micrograms per day and titrate upward over several weeks. These are reported patterns, not recommendations.
Q7: How do you reconstitute Adamax?
Only powder vials need reconstitution. The SubQ example on this page uses a 10 mg vial plus 3.0 mL BAC water, giving about 3.33 mg/mL. Add the water slowly, swirl gently, and refrigerate.
Q8: What are the side effects of Adamax?
No side-effect data has been collected for Adamax. Based on Semax and route-related issues, possible problems include nasal irritation, injection-site soreness, headache, irritability, or poor sleep. Long-term risks are unknown.
Q9: Where can I buy Adamax, and is it legal?
Adamax is sold by some research-chemical vendors as research-use-only material, not for human use. Legal status depends on your country and can change. This page does not endorse personal use.
Q10: Is this page medical advice?
No. This is an educational research reference, not medical advice. Adamax is an unstudied research compound with no approved medical use.
Sources & Research
- 1. Ceretropic founder statement (reported) Adamax was developed with no human clinical research or research of any kind; treat as a research compound. Jay Campbell (creator quote and Adamax/Ceretropic history) (2026)
- 2. SemaxPolska (educational overview) Adamax is an experimental concept, lacks significant human clinical trials, and many reported effects are anecdotal. semaxpolska.com (2026)
- 3. Dolotov OV, Karpenko EA, Inozemtseva LS, et al. Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus. [Parent peptide: Semax, not Adamax] Brain Research (1117:54-60) (2006)
- 4. Dolotov OV, et al. Semax, an analogue of ACTH(4-10), binds specifically and increases BDNF protein in rat basal forebrain. [Parent peptide: Semax, not Adamax] Journal of Neurochemistry (2006)
- 5. Shadrina MI, Dolotov OV, Grivennikov IA, et al. Rapid and efficient NGF and BDNF mRNA induction in rat glial cell cultures by ACTH(4-10) analog Semax. [Parent peptide context] Neuroscience Letters (308:115-118) (2001)
- 6. Springer (Journal of Molecular Neuroscience) Comparison of the temporal dynamics of NGF and BDNF gene expression under Semax action. [Parent peptide context] Journal of Molecular Neuroscience (2009)
- 7. Medsbase (educational guide) Adamax structure (N-acetyl-Semax + C-terminal adamantane) and research-use framing. medsbase.com (2026)
- 8. Research-chemical vendor listing Adamax sold as research-use-only, not for human use (product form: 10 mg vial / nasal spray). Vendor product page (for form/RUO status only) (2026)
Related Dosing Protocols
Educational use only
This guide is an educational research reference, not medical advice or a treatment plan. Adamax has no clinical trials. Dosing figures are community-reported, not validated, and not recommendations.
Calculate vial math
Use the calculator for custom vial size, BAC-water volume, and syringe-unit math.
Written by Garret Grant
Founder & Lead Researcher · B.S. Civil Engineering, UCLA
Last updated: July 2026
Human-researched and AI-assisted with full editorial review. I verify sources, protocol interpretation, and final judgments personally. See methodology.
Share this page


